# Problem Statement — Why the World Needs Puffy

> “Nicotine is harder to quit than heroin.” — World Health Organization (2024)

**1. The Scale of Harm**

* **More than 8 million deaths every year** are directly attributable to tobacco use, making it one of the planet’s biggest, fully-preventable killers. Over 80 % of those deaths occur in low- and middle-income countries where cessation support is weakest. ([World Health Organization](https://www.who.int/health-topics/tobacco?utm_source=chatgpt.com))
* Smoking drains the global economy of **≈ US $1.4–1.9 trillion annually** in health-care expenses and lost productivity—about 1.7 % - 1.8 % of world GDP. ([Tobacco Control](https://tobaccocontrol.bmj.com/content/27/1/58?utm_source=chatgpt.com), [UICC](https://www.uicc.org/what-we-do/thematic-areas/tobacco-control?utm_source=chatgpt.com))

**2. Current Cessation Tools Under-deliver**

| Modality                                              | Typical 6- to 12-mo quit rate                                                                                                                                                                                                                                               | Core issues                                                                                                                              |
| ----------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------- |
| **Nicotine-Replacement Therapy (patch, gum, sprays)** | **10-17 %** (Number Needed to Treat ≈ 15) ([TheNNT](https://thennt.com/nnt/nicotine-replacement-therapy-for-smoking-cessation/?utm_source=chatgpt.com))                                                                                                                     | Low adherence, OTC misuse, weak positive reinforcement ([PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC4194355/?utm_source=chatgpt.com)) |
| **Smart-phone Cessation Apps**                        | **4-18 %** sustained abstinence; high 20-30 % attrition by month 6 ([PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7506605/?utm_source=chatgpt.com), [BioMed Central](https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-019-7723-z?utm_source=chatgpt.com)) | One-directional reminders, limited real-time feedback                                                                                    |
| **E-cigarettes**                                      | About **2×** as effective as NRT at one year—**but 80 % of users still inhale nicotine** through the new device, perpetuating dependence. ([TIME](https://time.com/5517247/e-cigs-more-effective-helping-smokers-quit-study/?utm_source=chatgpt.com))                       |                                                                                                                                          |

> **Gap:** Existing approaches either **punish relapse** (guilt-based counselling) or **substitute the drug** (vapes, NRT) without creating a **compelling, data-driven reward** for real behavioural change.

**3. Behavioural & Technical Friction**

* **Mis-aligned profit models**\
  \&#xNAN;*Traditional nicotine-replacement products (patches, gums, e-cigs) make money while users keep buying—­they succeed economically when you fail behaviourally.*\
  Pharmacies and vape brands have no financial upside if you quit completely, so their product road-maps optimise for ongoing dependence, not cessation.
* **Delayed gratification**\
  Health benefits (better lung capacity, lower cancer risk) arrive months or years later, while the immediate “hit” of nicotine is felt in seconds. Without an instant, tangible reward, most quit attempts collapse within **10 days**.
* **Data Black-Box:** Clinicians still rely on self-reported cigarette counts or expensive lab tests. Users can easily under-report; providers can’t verify progress in real time.

**4. Equity & Access Constraints**

* Nicotine-addicted populations in LMICs spend **up to 10 % of household income** on cigarettes, leaving little budget for paid quit programs.
* Hardware-centric solutions often ship only to North America/EU, widening the health-equity gap.

***

#### Where Puffy Fits

| Problem Pain-Point                  | Puffy’s Response                                                                                                                          |
| ----------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------- |
| **No real-time reward**             | Blockchain-secured daily PUFFY payouts scale 2 × when users drop to 0 % pods.                                                             |
| **Low engagement / high attrition** | Game loops (streaks, NFT upgrades, squad leaderboards) create constant micro-goals.                                                       |
| **Data credibility**                | On-device secured chip verifies pod strength; signed telemetry posted to Solana—tamper evident.                                           |
| **Economic burden of relapse**      | Token sinks (pod upgrades, cosmetic flex, competition entry) recycle PUFFY into the ecosystem, funding rewards without runaway inflation. |

Puffy’s quit-to-earn architecture tackles **medical, behavioural, and economic** failure points simultaneously—turning nicotine reduction from an act of willpower into a transparent, financially-backed game that anyone can join.


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://puffy.gitbook.io/puffy-litepaper/intro-to-puffy/what-is-puffy/problem-statement-why-the-world-needs-puffy.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.